BioSpace News Archive

The global market for oral appliances, the treatment options increasingly prescribed to non-invasively treat snoring and obstructive sleep apnea, has started to pick up pace and is slated to exhibit a promising pace of expansion in the next few years.

iSTAR Medical, a med-tech company developing minimally-invasive implants for glaucoma surgery, announced that the U.S. Food and Drug Administration granted it Investigational Device Exemption to start a pivotal trial with MINIjectTM.

XOMA Corporation, announced it has acquired the royalty interest position Kuros Biosciences holds in Checkmate Pharmaceuticals’ vidutolimod, an advanced-generation Toll-like receptor 9 agonist packaged in a virus-like particle, for $7.0 million upfront plus sales milestones.

Mentice AB announces that the company will present its interim report via webcast conference call with the opportunity for interested parties to ask questions to CEO Göran Malmberg and CFO Elisabet Lund.

West Pharmaceutical Services, Inc., a global leader in innovative solutions for injectable drug administration, announced that it will release second-quarter 2021 financial results before the market opens on Thursday, July 29, 2021, and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time.

Thoracoscopy is a minimally invasive procedure performed by a pulmonary specialist for the diagnosis and treatment of disorders related to chest cavity.

Morcellators are class II medical devices used during laparoscopic procedures. The device cuts tissues into smaller pieces, which can be removed with the help of laparoscopes.

Aragen Life Sciences, a leading Contract Research and Development Organization, headquartered out of Hyderabad, India, announced that it has been selected by Skyhawk Therapeutics, a leader in the development of small molecule therapeutics that correct RNA expression, as its partner in India.

Microbiome Insights, a global leader for end-to-end microbiome sequencing and comprehensive bioinformatic analysis, announced today that it has received accreditation from the College of American Pathologists (CAP).

GENIXUS, a pharmaceutical company focused on transforming acute and critical care medicines, announced the completion of an expansion project within their Kannapolis, NC facility.